Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Graft-Versus-Tumor Effects

Expansion and activation of minor histocompatibility antigen HY-specific T cells associated with graft-versus-leukemia response

Summary:

The immune system of females is capable of recognizing and reacting against the male-specific minor histocompatibility antigen (mHA), HY. Thus, cytotoxic T-lymphocytes (CTLs) recognizing this antigen may be useful in eradicating leukemic cells of a male patient if they can be generated in vivo or in vitro from a human leukocyte antigen (HLA)-identical female donor. The HLA-A*0201-restricted HY antigen, FIDSYICQV, is a male-specific mHA. Using HLA-A2/HY peptide tetrameric complexes, we reveal a close association between the emergence of HY peptide-specific CD8+ T cells in peripheral blood and molecular remission of relapsed BCR/ABL+ chronic myelogenous leukemia in lymphoid blast crisis in a patient who underwent female-to-male transplantation. Assessment of intracellular cytokine levels identified T cells that produce interferon-γ in response to the HY peptide during the presence of HY tetramer-positive T cells. These results indicate that transplant with allogeneic HY-specific CTLs has therapeutic potential for relapsed leukemia, and that expansion of such T cells may be involved in the development of a graft-versus-leukemia response against lymphoblastic leukemia cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Mutis T, Goulmy E . Hematopoietic system-specific antigens as targets for cellular immunotherapy of hematological malignancies. Semin Hematol 2002; 39: 23–31.

    Article  Google Scholar 

  2. Mutis T, Gillespie G, Schrama E et al. Tetrameric HLA class I-minor histocompatibilty antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease. Nat Med 1999; 5: 839–842.

    Article  CAS  Google Scholar 

  3. Kern F, Surel IP, Brock C et al. T-cell epitope mapping by flow cytometry. Nat Med 1998; 4: 975–978.

    Article  CAS  Google Scholar 

  4. Kuzushima K, Hoshino Y, Fujii K et al. Rapid determination of Epstein–Barr virus-specific CD8+ T-cell frequencies by flow cytometry. Blood 1999; 94: 3094–3100.

    CAS  PubMed  Google Scholar 

  5. Meadows L, Wang W, den Haan JM et al. The HLA-A*0201-restricted H-Y antigen contains a post translationally modified cysteine that significantly affects T cell recognition. Immunity 1997; 6: 273–281.

    Article  CAS  Google Scholar 

  6. Kondo Y, Shiobara S, Nakao S . Identification of T-cell clones showing expansion associated with graft-versus-leukemia effect on chronic myelogenous leukemia in vivo and in vitro. Exp Hematol 2001; 29: 471–476.

    Article  CAS  Google Scholar 

  7. Verdijk RM, Mutis T, Wilke M et al. Exclusive TCRVbeta chain usage of ex vivo generated minor histocompatibility antigen HA-1 specific cytotoxic T cells: implications for monitoring of immunotherapy of leukemia by TCRBV spectratyping. Hematol J 2002; 3: 271–275.

    Article  CAS  Google Scholar 

  8. Kuzushima K, Hayashi N, Kudoh A et al. Tetramer-assisted identification and characterization of epitopes recognized by HLA A*2402-restricted Epstein–Barr virus-specific CD8+ T cells. Blood 2003; 101: 146–1468.

    Article  Google Scholar 

  9. Redchenko IV, Rickinson AB . Accessing Epstein–Barr virus-specific T-cell memory with peptide-loaded dendritic cells. J Virol 1999; 73: 334–342.

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Nakao S, Takami A, Takamatsu H et al. Isolation of a T-cell clone showing HLA-DRB1*0405-restricted cytotoxicity for hematopoietic cells in a patient with aplastic anemia. Blood 1997; 89: 3691–3699.

    CAS  PubMed  Google Scholar 

  11. Chomczynski P, Sacchi N . Single step method of RNA isolation by acid guanidium thiocyanate phenol–chloroform extraction. Anal Biochem 1987; 162: 156–159.

    Article  CAS  Google Scholar 

  12. Currier JR, Deulofeut H, Barron KS, Kehn PJ, Robinson MA . Mitogens, superantigens, and nominal antigens elicit distinctive patterns of TCRB CDR3 diversity. Hum Immunol 1996; 48: 39–51.

    Article  CAS  Google Scholar 

  13. Waase I, Kayser C, Carlson PJ et al. Oligoclonal T cell proliferation in patients with rheumatoid arthritis and their unaffected siblings. Arthritis Rheum 1996; 39: 904–914.

    Article  CAS  Google Scholar 

  14. Casanova JL, Pannetier C, Jaulin C, Kourilsky P . Optimal conditions for directly sequencing double-stranded PCR products with sequenase. Nucleic Acids Res 1990; 18: 4028.

    Article  CAS  Google Scholar 

  15. Goulmy E, Schipper R, Pool J et al. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med 1996; 334: 281–285.

    Article  CAS  Google Scholar 

  16. Maruya E, Saji H, Seki S et al. Evidence that CD31, CD49b, and CD62L are immunodominant minor histocompatibility antigens in HLA identical sibling bone marrow transplants. Blood 1998; 92: 2169–2176.

    CAS  Google Scholar 

  17. Marijt WA, Heemskerk MH, Kloosterboer FM et al. Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia. Proc Natl Acad Sci USA 2003; 100: 2742–2747.

    Article  CAS  Google Scholar 

  18. Gratwohl A, Hermans J, Niederwieser D et al. Female donors influence transplant-related mortality and relapse incidence in male recipients of sibling blood and marrow transplants. Hematol J 2002; 2: 363–370.

    Article  Google Scholar 

  19. Mutis T, Verdijk R, Schrama E et al. Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens. Blood 1999; 93: 2336–2341.

    CAS  Google Scholar 

  20. Gallardo D, Arostegui JI, Balas A et al. Disparity for the minor histocompatibility antigen HA-1 is associated with an increased risk of acute graft-versus-host disease (GvHD) but it does not affect chronic GvHD incidence, disease-free survival or overall survival after allogeneic human leucocyte antigen-identical sibling donor transplantation. Br J Haematol 2001; 114: 931–936.

    Article  CAS  Google Scholar 

  21. Teshima T, Ordemann R, Reddy P et al. Acute graft-versus-host disease does not require alloantigen expression on host epithelium. Nat Med 2002; 8: 575–581.

    Article  CAS  Google Scholar 

  22. Becker C, Pohla H, Frankenberger B et al. Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay. Nat Med 2001; 7: 1159–1162.

    Article  CAS  Google Scholar 

  23. Nazaruk RA, Rochford R, Hobbs MV, Cannon MJ . Functional diversity of the CD8+ T-cell response to Epstein–Barr virus (EBV): implications for the pathogenesis of EBV-associated lymphoproliferative disorders. Blood 1998; 91: 3875–3883.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Health, Labor and Welfare. We wish to thank Megumi Yoshii for the excellent technical assistance as well as her patience in preparation of the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A Takami.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Takami, A., Sugimori, C., Feng, X. et al. Expansion and activation of minor histocompatibility antigen HY-specific T cells associated with graft-versus-leukemia response. Bone Marrow Transplant 34, 703–709 (2004). https://doi.org/10.1038/sj.bmt.1704583

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704583

Keywords

Search

Quick links